Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-04-0161PMID 15827327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma

  2004cited by this paper
• Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy

  2004cited by this paper
• Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

  2003cited by this paper
• A Phase II study of irinotecan in patients with advanced renal cell carcinoma

  2003cited by this paper
• Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma.

  2003influential reference
• Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5.

  2003influential reference
• The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.

  2002cited by this paper
• Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells.

  2002cited by this paper
• A Phase II study of irinotecan in patients with advanced hepatocellular carcinoma

  2001cited by this paper
• Irinotecan (CPT-11): recent developments and future directions--colorectal cancer and beyond.

  2001cited by this paper
• Intra-abdominal pressure monitoring as a guideline in the nonoperative management of blunt hepatic trauma.

  2001cited by this paper
• Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs.

  2000cited by this paper
• Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.

  2000cited by this paper
• Role of Blood Vessels in Producing Pathological Changes in the Brain with Alzheimer's Disease

  2000cited by this paper
• Mechanisms of Resistance to Camptothecins

  2000cited by this paper
• The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin.

  1999cited by this paper
• ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P.

  1999cited by this paper
• MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs

  1999cited by this paper
• Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells

  1999cited by this paper
• Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

  1999influential reference
• Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter.

  1998cited by this paper
• A phase II trial of irinotecan in hormone-refractory prostate cancer

  1998cited by this paper
• Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?

  1997cited by this paper
• A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.

  1997cited by this paper
• Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.

  1996influential reference
• Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma.

  1994cited by this paper
• Camptothecin overcomes MDR1-mediated resistance in human KB carcinoma cells.

  1991cited by this paper
• Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

  1985cited by this paper
• Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line

  1982cited by this paper

• Targeting MRP4 in drug resistance and aspirin treatment failure: implications for precision medicine.

  2026cites this paper
• Arginine-axis transcriptomics define three neuroblastoma subtypes and a fixed four-gene prognostic signature with immune correlations

  2025cites this paper
• Overcoming resistance to antibody-drug conjugates: from mechanistic insights to cutting-edge strategies

  2025cites this paper
• Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs

  2024cites this paper
• Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models.

  2024cites this paper
• Structural View of Cryo-Electron Microscopy-Determined ATP-Binding Cassette Transporters in Human Multidrug Resistance

  2024cites this paper
• Advances and challenges in therapeutic resistant biomarkers of neuroblastoma: A comprehensive review.

  2024cites this paper
• Machine learning methods revealed the roles of immune-metabolism related genes in immune infiltration, stemness, and prognosis of neuroblastoma

  2023cites this paper
• TDP1-independent pathways in the process and repair of TOP1-induced DNA damage

  2022cites this paper
• Specific MRP4 Inhibitor Ceefourin-1 Enhances Apoptosis Induced by 6-Mercaptopurine in Jurkat Leukemic Cells, but Not in Normal Lymphoblast Cell Line CRL-1991

  2022cites this paper
• Structural and Mechanistic Basis of Substrate Transport by the Multidrug Transporter MRP4

  2022cites this paper
• Excellent Early Outcomes of Combined Chemotherapy With Arsenic Trioxide for Stage 4/M Neuroblastoma in Children: A Multicenter Nonrandomized Controlled Trial

  2021cites this paper
• Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance.

  2021cites this paper
• HnRNPA1 and Its Effect in the Expression of ABCC (ABCC4 and ABCC6) Transporter in Glioma Cell Lines

  2020cites this paper
• Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness

  2020cites this paper
• Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation.

  2020cites this paper
• Mouse models of high-risk neuroblastoma

  2020cites this paper
• ABCC4/MRP4 contributes to the aggressiveness of Myc‐associated epithelial ovarian cancer

  2020cites this paper
• The Effect of Hyperthermia on the Gene Expression of MDR1 and MRP4 Drug Efflux in Colorectal Cancer Cells

  2020cites this paper
• Effect of ABC transporter expression and mutational status on survival rates of cancer patients.

  2020cites this paper
• ABC transporters as cancer drivers: Potential functions in cancer development.

  2019cites this paper
• MRP4/ABCC4 As a New Therapeutic Target: Meta-Analysis to Determine cAMP Binding Sites as a Tool for Drug Design.

  2019cites this paper
• Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics.

  2019cites this paper
• CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.

  2019cites this paper
• Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics.

  2019cites this paper
• Mechanisms of therapy-resistance modulated by GRP78, SPARC and HSP47 in colorectal cancer

  2019cites this paper
• A Human ABC Transporter ABCC4 Gene SNP (rs11568658, 559 G > T, G187W) Reduces ABCC4-Dependent Drug Resistance

  2019cites this paper
• The Effects of Synthetically Modified Natural Compounds on ABC Transporters

  2018cites this paper
• Neuroblastoma

  2018cites this paper
• Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4

  2017cites this paper
• The effects of selective inhibitors of N-Glycosylation and Endoplasmic Reticulum stress inducers on Neuroblastoma cell proliferation and Apoptosis

  2017cites this paper
• MRP4 regulates ENaC-dependent CREB/COX-2/PGE2 signaling during embryo implantation

  2017cites this paper
• Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.

  2017cites this paper
• ABC Transporters Involved in Cholestasis

  2017cites this paper
• Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors.

  2016cites this paper
• Drug Transporters and Multiple Drug Resistance in the Most Common Pediatric Solid Tumors

  2016cites this paper
• MRP1 expression in CTCs confers resistance to irinotecan‐based chemotherapy in metastatic colorectal cancer

  2016cites this paper
• ABC transporters as mediators of drug resistance and contributors to cancer cell biology.

  2016cites this paper
• Lipid-coated polymeric nanoparticles for cancer drug delivery.

  2015cites this paper
• ABC transporters and neuroblastoma.

  2015cites this paper
• Quantitative interactome analysis reveals a chemoresistant edgotype

  2015cites this paper
• Dual Role of cAMP in the Transcriptional Regulation of Multidrug Resistance-Associated Protein 4 (MRP4) in Pancreatic Adenocarcinoma Cell Lines

  2015cites this paper
• The Pharmacological and Physiological Role of Multidrug-Resistant Protein 4

  2015cites this paper
• Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen.

  2015cites this paper
• Clinical Relevance of Multidrug-Resistance-Proteins (MRPs) for Anticancer Drug Resistance and Prognosis

  2015cites this paper
• Using mouse models to learn about mitochrondial DNA point mutations in ageing and disease

  2015cites this paper
• Quantitative Determination of Irinotecan and the Metabolite SN-38 by Nanoflow Liquid Chromatography-Tandem Mass Spectrometry in Different Regions of Multicellular Tumor Spheroids

  2015cites this paper
• Silencing of the ABCC4 gene by RNA interference reverses multidrug resistance in human gastric cancer.

  2015cites this paper
• Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.

  2014cites this paper
• aBcc4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer

  2014cites this paper
• Membrane transporters and transporter substrates as biomarkers for drug pharmacokinetics, pharmacodynamics, and toxicity/adverse events

  2014cites this paper
• ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer

  2014cites this paper
• A Drosophila ABC Transporter Regulates Lifespan

  2014cites this paper
• Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo.

  2014cites this paper
• Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia

  2014cites this paper
• Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance

  2014cites this paper
• High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4).

  2014cites this paper
• Upregulation of COX-2 in the lung cancer promotes overexpression of multidrug resistance protein 4 (MRP4) via PGE2-dependent pathway.

  2014cites this paper
• ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma.

  2014cites this paper
• The MYCN Oncogene

  2013cites this paper
• Pharmacokinetics and pharmacogenetics of actinomycin D in children with cancer

  2013cites this paper
• Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂.

  2013cites this paper
• Augmented epithelial multidrug resistance-associated protein 4 expression in peritoneal endometriosis: regulation by lipoxin A(4).

  2013cites this paper
• Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine

  2013cites this paper
• Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma

  2013influential citation
• Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.

  2013cites this paper
• Downregulation of ATP-Binding Cassette Subfamily C Member 4 Increases Sensitivity to Neoadjuvant Radiotherapy for Locally Advanced Rectal Carcinoma

  2013cites this paper
• Clinicopathological Impact of ABCC1/MRP1 and ABCC4/MRP4 in Epithelial Ovarian Carcinoma

  2013cites this paper
• Warburg effect and translocation-induced genomic instability: two yeast models for cancer cells

  2013cites this paper
• Discovering combinatorial disease biomarkers

  2012cites this paper
• Knockdown of MRP4 by lentivirus-mediated siRNA improves sensitivity to adriamycin in adriamycin-resistant acute myeloid leukemia cells

  2012cites this paper
• Effects of 3β-Acethyl Tormentic Acid (3ATA) on ABCC Proteins Activity

  2012cites this paper
• Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK

  2012cites this paper
• A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma

  2012cites this paper
• Contribution of tumoral and host solute carriers to clinical drug response.

  2012cites this paper
• 3β-Acetyl Tormentic Acid (3ATA) a Novel Modulator of ABCC Proteins Activity

  2012cites this paper
• ABC Drug Transporters and Their Impact on Drug Disposition/Drug Sensitivity and Resistance

  2012cites this paper
• The ABCC4 gene is a promising target for pancreatic cancer therapy.

  2012cites this paper
• Small Molecule Drugs and Targeted Therapies for Neuroblastoma

  2012cites this paper
• ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma

  2012cites this paper
• Targeting Multidrug Resistance in Neuroblastoma

  2012cites this paper
• Multidrug resistance protein (MRP) 4 attenuates benzo[a]pyrene-mediated DNA-adduct formation in human bronchoalveolar H358 cells.

  2012cites this paper
• High-Order SNP Combinations Associated with Complex Diseases: Efficient Discovery, Statistical Power and Functional Interactions

  2012cites this paper
• N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma.

  2012cites this paper
• Pre-clinical metabolism studies with Fenretinide in paediatric cancer

  2011cites this paper
• Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells.

  2011cites this paper
• Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity.

  2011cites this paper
• Characterization of Abcc4 Gene Amplification in Stepwise-Selected Mouse J774 Macrophages Resistant to the Topoisomerase II Inhibitor Ciprofloxacin

  2011cites this paper
• ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux

  2011influential citation
• [Transmembrane transporters ABCC - structure, function and role in multidrug resistance of cancer cells].

  2011cites this paper
• The connections between neural crest development and neuroblastoma.

  2011cites this paper
• P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice.

  2010influential citation
• Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell.

  2010cites this paper
• chromosomal translocation event in Saccharomyces cerevisiae.

  2010cites this paper
• Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.

  2010cites this paper
• Different Aneuploidies Arise From the Same Bridge-Induced Chromosomal Translocation Event in Saccharomyces cerevisiae

  2010cites this paper
• Myc-mediated control of gene transcription in cancer cells

  2010cites this paper
• ABC transporters in cancer: more than just drug efflux pumps

  2010cites this paper
• ELIISA MANNERMAA In vitro Model of Retinal Pigment Epithelium for Use in Drug Delivery

  2010cites this paper
• Vectorial Transport of Nucleoside Analogs from the Apical to the Basolateral Membrane in Double-Transfected Cells Expressing the Human Concentrative Nucleoside Transporter hCNT3 and the Export Pump ABCC4

  2010cites this paper